2m 2m 2m 2m 2m 2m 2m
- $5.5BMarket Cap
- 13.66%1-Year Change
- Specialty ChemicalsIndustry
Balchem Corp (BCPC)
Key Performance
More- Earnings Score: 82
- Momentum Score: 49
- True Yield: 84
- Financial Health Score: 96
Latest Research & News
Balchem: 3 Key Takeaways for Long-Term Investors
Balchem reported record Q3 2026 sales of $291 million with 8.6% year-over-year growth. The company is expanding its science-backed specialty ingredients like VitaCholine and K2VITAL DELTA from infant nutrition into adult cognitive and cardiovascular markets. Proprietary encapsulation technology is driving adoption in animal nutrition, while a high-margin product mix is fueling segment profitability. The company achieved its 29th consecutive quarter of year-over-year adjusted EBITDA growth.
10/23/2026, 2:12 PM • The Motley Fool
Balchem Corporation Reports Third Quarter 2026 Financial Results
Balchem Corporation reported record third quarter 2026 results with net sales of $290.7 million (up 8.6% YoY), net earnings of $46.7 million (up 16.0% YoY), and adjusted EBITDA of $80.3 million (up 12.4% YoY). All three business segments showed healthy growth, with the company maintaining a strong balance sheet and executing strategic growth initiatives including $127 million in share repurchases over the trailing twelve months.
10/23/2026, 7:00 AM • GlobeNewswire
Brunswick Corporation Declares Quarterly Dividend
Brunswick Corporation announced a quarterly dividend of $0.44 per share, payable on December 15, 2026, to shareholders of record as of November 24, 2026. The marine recreation company, headquartered in Mettawa, Illinois, operates over 60 industry-leading brands across marine propulsion, parts, accessories, and electronics.
10/19/2026, 6:31 PM • GlobeNewswire
Balchem Corporation announced a conference call scheduled for October 23, 2026, at 11:00 AM ET to discuss third quarter 2026 financial results. CEO Ted Harris and CFO Martin Bengtsson will host the call, with results to be published prior to market opening. The call will be available via phone and webcast.
10/09/2026, 7:00 AM • GlobeNewswire
Brunswick Corporation Schedules 2026 Third Quarter Earnings Conference Call
Brunswick Corporation announced it will release its 2026 third quarter financial results on October 29, 2026, followed by a conference call at 10 a.m. CT hosted by CEO David M. Foulkes and other executives. The company is a global leader in marine recreation with over 60 brands and approximately 14,000 employees across 26 countries.
10/08/2026, 6:00 AM • GlobeNewswire
The global encapsulated lactic acid market is projected to grow from USD 1.45 billion in 2026 to USD 2.01 billion by 2031, with a CAGR of 6.72%. Growth is driven by rising demand in nutraceuticals, probiotics, and functional foods, with liquid formats showing the fastest growth at 8.02% CAGR. However, high encapsulation costs and manufacturing complexity remain key challenges. North America leads with 40.21% market share, while Asia-Pacific is the fastest-growing region at 7.62% CAGR.
09/02/2026, 8:00 AM • GlobeNewswire
Brunswick Corporation Releases Investor Day Materials Highlighting Long-Term Growth Strategy
Brunswick Corporation made its 2026 Investor Day materials available, including a recorded strategy presentation and slides detailing the company's strategic priorities, growth opportunities, and financial outlook. The materials are accessible on the company's Investor Relations website.
08/03/2026, 6:59 PM • GlobeNewswire
The global encapsulated essential oils for feed market is projected to grow from $1.18 billion in 2026 to $1.67 billion by 2030, with a CAGR of 9.1%. Key growth drivers include rising demand for antibiotic-free livestock production, natural gut-health additives, controlled-release encapsulation technologies, and aquaculture-specific feeds, particularly in Asia-Pacific regions.
07/15/2026, 4:11 AM • GlobeNewswire
Brunswick Corporation Schedules 2026 Second Quarter Earnings Conference Call
Brunswick Corporation will release its 2026 second quarter financial results on July 30, 2026, followed by a conference call at 10 a.m. CT. The company, a global leader in marine recreation with brands including Mercury Marine, Boston Whaler, and Sea Ray, operates approximately 14,000 employees across 26 countries. The earnings announcement will be hosted by CEO David M. Foulkes and CFO Ryan M. Gwillim.
07/09/2026, 6:00 AM • GlobeNewswire
Balchem Corporation announced its participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026, with key executives including CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter attending the event.
06/26/2026, 7:00 AM • GlobeNewswire
Brunswick Corporation Announces Operational Updates at Lowell Facility
Navico Group, a division of Brunswick Corporation, announced operational changes at its Lowell, Michigan facility aimed at reducing fixed costs and improving efficiency. The plan includes expanding insourcing, partnering with select outside companies, and closer collaboration with other Brunswick divisions. Land 'N' Sea will occupy approximately 50,000 square feet of space for distribution operations while maintaining separate leadership and operations. These changes are expected to generate multi-million-dollar savings while supporting U.S.-based manufacturing.
06/22/2026, 7:00 AM • GlobeNewswire
Brunswick Corporation achieved a record 15 Boating Industry Magazine Top Product Awards for 2026 across 13 brands, including innovations in autonomous boating systems, propulsion technology, and marine electronics. The awards recognize the company's innovation pipeline and category leadership in the marine industry.
05/26/2026, 2:59 PM • GlobeNewswire
Brunswick Corporation announced a collaboration with Textron Systems to provide vessels, propulsion systems, and electronics for TSUNAMI Uncrewed Surface Vessels (USVs) following Textron Systems' contract award from the Defense Innovation Unit. The USVs will support U.S. Navy Fleet Experimentation exercises and joint operations with SOUTHCOM and the U.S. Navy Fourth Fleet, showcasing Brunswick's integrated technology portfolio combined with Textron's autonomy capabilities.
05/08/2026, 12:13 PM • GlobeNewswire
Brunswick Corporation Declares Quarterly Dividend
Brunswick Corporation (NYSE:BC) announced a quarterly dividend of $0.44 per share, payable on June 15, 2026, to shareholders of record as of May 18, 2026. The global marine recreation leader, headquartered in Mettawa, Illinois, operates approximately 14,500 employees across 26 countries with over 60 industry-leading brands.
05/05/2026, 2:51 PM • Benzinga
Brunswick Corporation Declares Quarterly Dividend
Brunswick Corporation announced a quarterly dividend of $0.44 per share, payable on June 15, 2026, to shareholders of record as of May 18, 2026. The global marine recreation leader, headquartered in Mettawa, Illinois, operates approximately 14,500 employees across 26 countries with over 60 industry-leading brands in marine propulsion, parts, accessories, and electronics.
05/05/2026, 2:51 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 10/23/2026
Company Profile
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Key Executives
- Theodore L. Harris
- Carl Martin Bengtsson
- Frederic Boned
- Hatsuki Miyata
- Brent Tignor
Current Ownership Distribution
- Institutions559.3M (75.83%)
- Mutual Funds177.6M (24.08%)
- Insiders707,040 (0.10%)
- Other0 (0.00%)